Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
Rheon Medical, a spin-off from the Swiss Federal Institute of Technology Lausanne (EPFL), is dedicated to revolutionizing the surgical treatment of glaucoma. Their flagship product, the eyeWatch system, is an adjustable glaucoma drainage device that offers a state-of-the-art solution for patients with refractory glaucoma. By allowing for non-invasive adjustment of intraocular pressure, the eyeWatch system has shown unprecedented success in reducing IOP, minimizing the need for anti-glaucoma drugs, and preventing hypotony. With a strong team of experts and a focus on developing novel technologies to improve treatment efficacy and patient outcomes, Rheon Medical aims to become a global leader in the glaucoma device market.
Nikolaos Stergiopoulos, Stéphane Bigler, Julien Maxime Gerber, Soroush Rafiei